NEJM Ferr S, Bhargava R, Engel J
Compounded medications The For semaglutide, the FDA has adverse effects after use of compounded semaglutide compounded versions that contain ingredients different from the marketed active ingredients fraudulent and unapproved marketed semaglutide with too little, too much, or no active semaglutide In a nausea vomiting abdominal pain Two people self-administered more than 10 times the recommended semaglutide dose
Research without Compromise
Current NICE guidance (NG28 for type 2 diabetes, TA875 for semaglutide 2.4mg, and TA664 for liraglutide 3.0mg) does not include inflammatory conditions as indications
Body Weight and Composition Larger body size doesnt dramatically affect semaglutide half-life, but it can influence the volume of distribution
Providers can incorporate these elements at their discretion, creating a more well-rounded and supportive treatment experience